Magnesium Sulfate in Bronchial Asthma and Acute Bronchiolitis in Children

Launched by ASSIUT UNIVERSITY · Apr 25, 2025

Keywords

ClinConnect Summary

This clinical trial is studying the use of magnesium sulfate as a treatment for children with bronchial asthma and acute bronchiolitis. The goal is to see if magnesium sulfate can help improve breathing and reduce symptoms in young patients who are having a hard time with these respiratory conditions. The trial will include children aged between 1 month and 18 years who have been diagnosed with asthma or acute bronchiolitis, but it will not include those under 1 month old or over 18 years old, or those with specific heart conditions.

If your child participates in this trial, they may receive magnesium sulfate as part of their treatment plan. The trial is still in its planning stages and has not started recruiting participants yet. The researchers hope that magnesium sulfate, which has fewer side effects and is less expensive than some other treatments, could be a helpful option for managing asthma and bronchiolitis in children. Your child's health and safety will be a top priority throughout the study.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • All children more than 1 month and less than 18 years cases with bronchial asthma and acute bronchiolitis
• Exclusion Criteria:
• • All children less than 1 month and more than 18 years congenital heart disease